Table 3 Means ± SE and P-values for breed and season on the fatty acid profile of milk collected from 73 individual cows from two breeding groups (100% Holstein-Friesian, HF; 50% Holstein-Friesian:50% Jersey, HF × J) and different seasons in four low-input dairy farms in England and Wales.

From: Performance and milk quality parameters of Jersey crossbreds in low-input dairy systems

 

Breed

Season

Breed × Season

HF

HF × J

SE

P-value2

Spring

Summer

Autumn

SE

P-value2

n1 = 83

n1 = 95

n1 = 58

n1 = 66

n1 = 54

P-value2

Individual FA (g/kg total FA)

SFA

C4:0

27.2

29.8

0.66

0.015

24.3b

31.3a

29.9a

0.73

< 0.001

0.285

C6:0

25.7

27.6

0.44

0.001

27.9a

25.6b

27.0a

0.53

< 0.001

0.217

C8:0

13.6

14.9

0.29

< 0.001

16.0a

13.5b

13.4b

0.33

< 0.001

0.398

C10:0

30.4

33.4

0.83

0.002

36.9a

29.3b

30.0b

0.93

< 0.001

0.546

C12:0

36.4

40.1

1.00

< 0.001

45.7a

31.6c

38.7b

1.02

< 0.001

0.515

C14:0

115.0

119.6

1.57

0.011

117.1b

112.4c

124.0a

1.83

< 0.001

0.821

C16:0

306.8

311.8

5.71

0.356

276.0c

292.1b

366.7a

4.71

< 0.001

0.750

C18:0

94.0

100.2

2.55

0.186

94.1b

112.2a

82.6c

2.68

< 0.001

0.375

MUFA

VA

22.9

23.3

1.51

0.962

27.3a

29.4a

11.0b

1.50

< 0.001

0.313

OA

191.9

174.6

4.18

0.001

187.9a

197.1a

159.3b

4.78

< 0.001

0.887

PUFA

LA

10.1

9.55

0.421

0.233

13.2a

7.15c

9.38b

0.381

< 0.001

0.301

RA

11.3

10.1

0.70

0.150

11.9a

13.2a

6.26b

0.762

< 0.001

0.576

ALNA

6.95

7.01

0.256

0.992

8.51a

7.63b

4.56c

0.224

< 0.001

0.608

EPA

0.80

0.79

0.026

0.493

0.89a

0.87a

0.61b

0.026

< 0.001

0.611

DPA

1.15

1.12

0.035

0.857

1.18a

1.18a

1.01b

0.041

0.003

0.813

DHA

0.08

0.09

0.006

0.249

0.10a

0.09b

0.07b

0.008

0.003

0.233

FA groups (g/kg total FA)

SFA3

675.0

702.3

6.30

< 0.001

663.7b

673.3b

737.2a

6.71

< 0.001

0.674

MUFA4

277.2

253.5

5.22

< 0.001

279.5a

279.8a

229.7b

5.83

< 0.001

0.681

cis MUFA6

235.4

213.1

4.18

< 0.001

228.4a

234.9a

204.3b

5.02

< 0.001

0.766

trans MUFA7

41.8

40.4

1.83

0.454

51.1a

44.9b

25.4c

1.77

< 0.001

0.454

PUFA5

47.9

44.3

1.42

0.021

56.8a

47.0b

33.1c

1.26

< 0.001

0.586

cis PUFA8

23.7

23.0

0.61

0.273

28.9a

21.7b

19.2c

0.53

< 0.001

0.639

trans PUFA9

3.55

3.20

0.123

0.022

4.27a

3.33b

2.43c

0.119

< 0.001

0.479

cis/trans + trans/cis PUFA10

20.6

18.1

0.95

0.039

23.65a

21.92a

11.39b

0.952

< 0.001

0.731

n-311

13.9

13.9

0.49

0.996

16.1a

16.0a

8.92b

0.41

< 0.001

0.708

n-612

15.4

14.2

0.52

0.053

19.4a

11.6c

13.5b

0.45

< 0.001

0.322

n-3/n-6 ratio

0.99

1.06

0.050

0.048

0.90b

1.42a

0.68c

0.040

< 0.001

0.727

n-6/n-3 ratio

1.22

1.14

0.060

0.230

1.22b

0.76c

1.64a

0.048

< 0.001

0.327

trans FA13

45.3

43.6

1.91

0.400

55.4a

48.3b

27.9c

1.82

< 0.001

0.504

trans FA (exc. VA)

22.4

20.2

0.77

0.028

28.1a

18.9b

16.8b

0.68

< 0.001

0.762

Human health related indices

AI14

2.62

2.98

0.10

0.002

2.41b

2.47b

3.68a

0.097

< 0.001

0.135

TI15

2.77

3.06

0.10

0.004

2.39b

2.56b

3.92a

0.085

< 0.001

0.230

HH16

0.55

0.49

0.02

0.003

0.57a

0.58a

0.38b

0.020

< 0.001

0.992

Δ9-desaturase activity indicators

Δ9I17

3.00

2.76

0.005

< 0.001

3.04a

3.02a

2.54b

0.006

< 0.001

0.786

C14:1/C14:0

0.09

0.08

0.003

0.002

0.08b

0.08b

0.10a

0.003

< 0.001

0.450

C16:1/C16:0

0.07

0.06

0.001

< 0.001

0.06

0.06

0.06

0.002

0.202

0.567

OA/C18:0

2.16

1.79

0.054

< 0.001

2.07a

1.77b

2.09a

0.066

< 0.001

0.171

RA/VA

0.53

0.44

0.015

< 0.001

0.45b

0.45b

0.57a

0.017

< 0.001

0.032

  1. 1 n is the number of records used to calculate means.
  2. 2 Significances were declared at P < 0.05. Means within a row, for season, with different upper-case letters are significantly different according to Fisher’s protected least significant difference test (P < 0.05).
  3. 3SFA: C4:0, C5:0, C6:0, C7:0, C8:0, C9:0, C10:0, C11:0, C12:0, C13:0, C14:0, C15:0, C16:0, C17:0, C18:0, C20:0, C22:0, C24:0.
  4. 4MUFA: c9 C14:1, c9 C15:1, t9 C16:1, c9 C16:1, c9 C17:1, t6 + t7 + t8 C18:1, t9 C18:1, t10 C18:1, t11 C18:1, t12 + t13 + t14 C18:1, c9 C18:1 (OA), t15 C18:1, c11 C18:1, c12 C18:1, c13 C18:1, c14 + t16 C18:1, c15 C18:1, c15 C18:1, c10 C19:1, c5 C20:1, c8 C20:1, c13 C22:1, c15 C24:1.
  5. 5PUFA: t11t15 C18:2, t11t15 C18:2, t10t14 C18:2. C9t13 C18:2, t9t12 C18:2, t8c13 C18:2, c9t12 C18:2, t9c12 C18:2, t11c15 C18:2, c9c12 C18:2 (LA), two unidentified C18:2, c9c15 C18:2, c12c15 C18:2, c6c9c12 C18:3 (GLA), c9c12c15 C18:3 (ALN), c9t11 18:2 (RA), four unidentified conjugated linoleic acid (CLA) isomers, t11c13 C18:2 CLA, c9c13c15 C18:3, c11c14 C20:2, c9c11c15 C18:3, c8c11c14 C20:3, c11c14c17 C20:3, c5c8c11c14 C20:4, c13c16 C22:2, c5c8c14c17 C20:5 (EPA), c13c16c19 C22:3, c7c10c13c16 C22:4, c7c10c13c16c19 C22:5 (DPA), c7c10c13c16c19 C22:6 (DHA).
  6. 6cis MUFA: c9 C14:1, c9 C15:1, c9 C16:1, c9 C17:1, c9 C18:1 (OA), c11 C18:1, c12 C18:1, c13 C18:1, c14 C18:1, c15 C18:1, c10 C19:1, c5 C20:1, c8 C20:1, c13 C22:1, c15 C24:1.
  7. 7trans MUFA: t9 C16:1, t6 + t7 + t8 C18:1, t9 C18:1, t10 C18:1, t11 C18:1 (VA), t12 + t13 + t14 C18:1, t15 C18:1, t16 C18:1.
  8. 8cisPUFA: c9c12 C18:2 (LA), unidentified cis/cis C18:2, c9c15 C18:2, c12c15 C18:2, c6c9c12 C18:3 (GLA), c9c12c15 C18:3 (ALN), c9c13c15 C18:3, c11c14 C20:2, c9c11c15 C18:3, c8c11c14 C20:3, c11c14c17 C20:3, c5c8c11c14 C20:4, c13c16 C22:2, c5c8c11c14c17 C20:5 (EPA), c13c16c19 C22:3, c7c10c13c16 C22:4, c7c10c13c16c19 C22:5 (DPA), c7c10c13c16c19 C22:6 (DHA).
  9. 9trans PUFA:t11t15 C18:2, t10t14 C18:2, t9t12 C18:2, unidentified trans/trans C18:2, unidentified trans/trans CLA isomers.
  10. 10cis/trans + trans/cis PUFA: c9t13 C18:2, t8c13 C18:2, c9t12 C18:2, t9c12 C18:2, ct1014 + 1216 C18:2, t11c15 C18:2, unidentified cis/trans + trans/cis C18:2, RA, t11c13 CLA, unidentified cis/trans + trans/cis CLA.
  11. 11Omega-3 PUFA (n-3): t11t15 C18:2, t11c15 C18:2, c9c15 C18:2, c12c15 C18:2, c9c12c15 C18:3 (ALN), c9c13c15 C18:3, c9c11c15 C18:3, c11c14c17 C20:3, c5c8c11c14c17 C20:5 (EPA), c13c16c19 C22:3, c7c10c13c16c19 C22:5 (DPA), c7c10c13c16c19 C22:6 (DHA).
  12. 12Omega-6 PUFA(n-6): t9t12 C18:2, c9t12 C18:2, t9c12 C18:2, c9c12 C18:2 (LA), c6c9c12 C18:3 (GLA), c11c14 C20:2, c8c11c14 C20:3, c5c8c11c14 C20:4, c13c16 C22:2, c7c10c13c16 C22:4.
  13. 13trans FA: t9 C16:1, t6 + t7 + t8 C18:1, t9 C18:1, t10 C18:1, t11 C18:1 (VA), t12 + t13 + t14 C18:1, t15 C18:1, c14 + t16 C18:1. t9 C16:1, t6 + t7 + t8 C18:1, t9 C18:1, t10 C18:1, t11 C18:1 (VA), t12 + t13 + t14 C18:1, t15 C18:1, t11t15 C18:2, t10t14 C18:2, t9t12 C18:2, t11c15 C18:2, t11t15 C18:2, t10t14 C18:2, t9t12 C18:2, unidentified trans/trans C18:2, unidentified trans/trans CLA.
  14. 14Atherogenicity index = (C12:0 + 4 × C14:0 + C16:0)/(MUFA + PUFA), as described in Srednicka-Tober et al. 32.
  15. 15Thrombogenicity index = (C14:0 + C16:0 + C18:0)/[(0.5 × MUFA) + (0.5 × n-6) + (3 × n-3) + (n-3/n-6)] as described in Srednicka-Tober et al. 32.
  16. 16Hypocholesterolemic to hypercholesteremic ratio = (C18:1 cis9 + total PUFA) / (C12:0 + C14:0 + C16:0).
  17. 17Δ9-desaturase activity index = (c9 C14:1 + c9 C16:1 + OA + RA)/(c9C14:1 + c9 C16:1 + OA + RA + C14:0 + C16:0 + C18:0 + VA) as described in Kay et al.34.